LDDC-3: Artificial Intelligence in drug development, manufacturing and health care
After two successful previous editions, the 3rd edition of Leiden Drug Development Conference (LDDC) is set to take place on 19 September 2024. Organized by LUMC, Leiden University, Johnson & Johnson, and TNO, LDDC-3 promises to be a groundbreaking event. In an era of rapid technological advancement, artificial intelligence (AI) is transforming industries worldwide. At LDDC-3, we have decided to dedicate the entire conference to AI’s impact on drug development, manufacturing, and healthcare. Our program covers a wide spectrum, from advanced interaction modeling of 3D protein structures to extracting relevant insights from federated patient data. We will also address the ethical and practical implications of AI applications.
Check the program here.
Source: Hyphen Projects